Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Deciphera Pharmaceuticals Inc (DCPH)
Deciphera Pharmaceuticals Inc (DCPH) News

DCPH

Deciphera Pharmaceuticals (DCPH)

Deciphera Pharmaceuticals Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DCPH

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >>

Date	Time	Source	Headline	Symbol	Company
05/23/2023	7:00AM	Business Wire	Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
05/12/2023	4:06PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
05/08/2023	7:00AM	Business Wire	Deciphera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
05/03/2023	8:45AM	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
05/03/2023	7:10AM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
05/03/2023	7:07AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
05/03/2023	7:00AM	Business Wire	Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
04/26/2023	7:00AM	Business Wire	Deciphera Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 3, 2023	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
04/19/2023	7:00AM	Business Wire	Deciphera Pharmaceuticals to Present at the Stifel Virtual Targeted Oncology Days	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
03/23/2023	4:06PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
03/14/2023	5:53PM	Business Wire	Deciphera Pharmaceuticals Announces QINLOCK® Included in NCCN Guidelines® for the Treatment of Second-Line GIST Patients and FDA Grants Breakthrough Therapy Designation for QINLOCK in Second-Line GIST Patients with Mutations in KIT Exon 11 and 17/18	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
03/14/2023	5:32PM	Business Wire	Deciphera Pharmaceuticals Announces Eight Presentations Highlighting Discovery Research Programs at the American Association for Cancer Research (AACR) Annual Meeting 2023	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
03/01/2023	7:00AM	Business Wire	Deciphera Pharmaceuticals Announces Completion of Enrollment for Pivotal Phase 3 MOTION Study of Vimseltinib in TGCT	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/27/2023	7:00AM	Business Wire	Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/16/2023	4:19PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/14/2023	4:15PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/14/2023	12:33PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/14/2023	9:13AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/10/2023	9:43AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/09/2023	11:22AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/08/2023	4:17PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/08/2023	9:53AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/07/2023	8:43AM	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/07/2023	7:19AM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/07/2023	7:00AM	Business Wire	Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/03/2023	4:30PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/03/2023	9:55AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
02/02/2023	7:00AM	Business Wire	Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
01/31/2023	7:00AM	Business Wire	Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on February 7, 2023	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc
01/24/2023	4:02PM	Business Wire	Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares	NASDAQ:DCPH	Deciphera Pharmaceuticals Inc

Showing the most relevant articles for your search:NASDAQ:DCPH

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >>

Canopus Biopharma (PK)

Gold and GemStone Mining (PK)

Marketing Worldwide (PK)

Virexit Technologies (PK)

Bell Buckle (PK)

Ubiquitech Software (PK)

Brookmount Explorations (PK)

NioCorp Developments

Anavex Life Sciences

Fannie Mae (QB)

Decentral Life (PK)

Seven Arts Entertainment (PK)

Delayed Upgrade Clock